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Amyotrophic lateral sclerosis (ALS) is characterized by massive loss of motor neurons.
Data from ALS patients and experimental models indicate that mitochondria are severely
damaged within dying or spared motor neurons. Nonetheless, recent data indicate
that mitochondrial preservation, although preventing motor neuron loss, fails to prolong
lifespan. On the other hand, the damage tomotor axons plays a pivotal role in determining
both lethality and disease course. Thus, in the present article each motor neuron
compartment (cell body, central, and peripheral axons) of G93A SOD-1 mice was
studied concerning mitochondrial alterations as well as other intracellular structures. We
could confirm the occurrence of ALS-related mitochondrial damage encompassing total
swelling, matrix dilution and cristae derangement along with non-pathological variations
of mitochondrial size and number. However, these alterations occur to a different extent
depending on motor neuron compartment. Lithium, a well-known autophagy inducer,
prevents most pathological changes. However, the efficacy of lithium varies depending
on which motor neuron compartment is considered. Remarkably, some effects of lithium
are also evident in wild type mice. Lithium is effective also in vitro, both in cell lines and
primary cell cultures from the ventral spinal cord. In these latter cells autophagy inhibition
within motor neurons in vitro reproduced ALS pathology which was reversed by lithium.
Muscle and glial cells were analyzed as well. Cell pathology was mostly severe within
peripheral axons and muscles of ALS mice. Remarkably, when analyzing motor axons
of ALS mice a subtotal clogging of axoplasm was described for the first time, which
was modified under the effects of lithium. The effects induced by lithium depend on
several mechanisms such as direct mitochondrial protection, induction of mitophagy
and mitochondriogenesis. In this study, mitochondriogenesis induced by lithium was
confirmed in situ by a novel approach using [2-3H]-adenosine.
Keywords: mitochondria, amyotrophic lateral sclerosis, autophagy, lithium, G93A transgenic mouse, motor
neuron, electron microscopy, biogenesis of mitochondria
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is characterized by
progressive neurodegeneration of motor neurons within spinal
cord, brainstem, and motor cortex (Charcot, 1874; Boillée et al.,
2006). This may occur either sporadically (sALS) or depending
on a number of gene mutations with familial transmission
(fALS), all these mutations leading to autophagy impairment
(Pasquali et al., 2014; Cirulli et al., 2015). Twenty percent of
fALS occurs due to mutations in the gene coding for the enzyme
copper-zinc superoxide dismutase (SOD-1, Rosen et al., 1994),
which produces mitochondrial toxicity (Vehviläinen et al.,
2014) while being an autophagy substrate (Kabuta et al., 2006).
Both fALS and sALS are characterized by severe mitochondrial
alterations. In fact, altered mitochondria within motor neurons
of ALS patients were originally demonstrated by using electron
microscopy (Hart et al., 1977; Hirano et al., 1984a,b; Sasaki,
2011; Ruffoli et al., 2015). Mitochondrial alterations represent
a milestone within degenerating motor neurons in ALS. This
may occur either primarily, through direct neurotoxicity of
mutated proteins toward specific mitochondrial targets (Martin
et al., 2007; Vehviläinen et al., 2014), or it may be produced by a
defective clearance of altered mitochondria (impaired autophagy
and mitophagy).
The occurrence of defective autophagy in ALS was
demonstrated for the first time in the last decade (Fornai
et al., 2008a,b); and it was progressively validated through a
growing number of studies (Pasquali et al., 2009; Ferrucci et al.,
2010; Otomo et al., 2012; Shimada et al., 2012; Wang et al.,
2012; Castillo et al., 2013; Ikenaka et al., 2013; Barmada et al.,
2014; Cheng et al., 2015; Lee et al., 2015; Philips and Rothstein,
2015; Xiao et al., 2015; Yang et al., 2015) up to the very recent
confirmative work by Xie et al. (2015a,b). This evidence was
reviewed in this issue by Ruffoli et al. (2015). At the same time,
within ALS mitochondria an altered calcium buffering activity
is constantly described (Higgins et al., 2002; von Lewinski and
Keller, 2005; Jaiswal, 2013). This was intensely investigated
in the past two decades to elucidate the process of primary
mitochondrial damage (Barrett et al., 2014; Vehviläinen et al.,
2014), which still requires a prompt mitochondrial removal
(mitophagy; Fornai et al., 2008a; Laird et al., 2008; Pasquali
et al., 2009; Ruffoli et al., 2015) as well as the synthesis of
novel mitochondria (Fornai et al., 2008a,b; Melser et al., 2015;
Roy et al., 2015; Ruffoli et al., 2015). A few years ago we
demonstrated that, when removal of aged mitochondria within
motor neurons is promoted through the autophagy machinery
(mitophagy), a concomitant stimulation of the biogenesis of
novel mitochondria takes place (Fornai et al., 2008a,b). This is
now explained mechanistically by the recent work of Palikaras
et al. (2015a,b) who unraveled a specific signaling pathway which
binds mitophagy to mitochondriogenesis. Thus, an increase
of mitochondrial removal eventually leads to the biogenesis of
novel mitochondria (Palikaras et al., 2015a,b). This provides
the molecular mechanism explaining why lithium, which is a
powerful autophagy (and mitophagy) inducer (Sarkar et al.,
2005; Sarkar and Rubinsztein, 2006; Pasquali et al., 2010;
Klionsky et al., 2012; Motoi et al., 2014) concomitantly stimulates
mitochondriogenesis (Fornai et al., 2008a,b), while protecting
against primary mitochondrial damage (Bachmann et al., 2009)
and excitotoxicity in the spinal cord (Young, 2009; Calderó
et al., 2010; Fulceri et al., 2011). Despite mitochondria are key
in the course of motor neuron degeneration in ALS, recent
data demonstrate that, when mitochondria are protected in
ALS mice, the time course of motor palsy and lethality is not
modified (Parone et al., 2013). These data were obtained by
suppressing the synthesis of cyclophilin D (CycD-KO), which
contributes to the opening of the mitochondrial permeability
transition pore. These CycD-KO mice have been generated in
different strains of SOD-1 transgenic ALS mice. In all these
ALS mice knocking out CycD preserves mitochondria and
prevents the loss of motor neurons in the spinal cord. However,
no improvement of motor symptoms and survival is obtained
(Parone et al., 2013).This is due to the ongoing loss of peripheral
motor innervation which persists despite the preservation of
motor neuron perikaria.
Unexpectedly, in CycD-KO mice axonal mitochondria were
protected as it occurred upstream in the cell body despite muscle
denervation persisted. However, mitochondrial preservation
within motor axons of CycD-KO mice was measured by Parone
et al. (2013) only within ventral roots (proximal axons), while
motor axon degeneration was measured at peripheral level
within denervated muscles (distal axons). This leaves open the
chance that mitochondrial damage within peripheral axons still
occurs compared with proximal axons and cell bodies. This
calls for additional studies to document the ultrastructure of
distal (peripheral) compared with proximal axons before ruling
out the protective role of mitochondrial preservation. In fact, it
may occur that mitochondrial integrity measured in the ventral
root is no longer present in peripheral axons. On the other
hand, if mitochondrial alterations in distal axons are prevented
despite an ongoing muscle denervation, alternative hypothesis
of pathological targets need to be taken into account. In this
context, altered axonal structure beyond mitochondria needs
to be investigated. In recent years, the axonal transport was
shown to be impaired in ALS. This may lead to abnormal
accumulation of organelles and protein aggregates. In this way,
a combined defect in axonal transport including mitochondria
may converge in determining axonal damage. For instance, a
specific impairment of axonal transport for mitochondria in
G93A mice was clearly documented (Magrané et al., 2012, 2014).
Since mitochondria are mostly synthesized at the level of the
cell body, this may lead to increasing deficit of mitochondria
along axonal length. This is expected to produce the most severe
mitochondrial reduction at the level of the most remote segments
of distal axons. If this is the case, apart from mitochondrial
protection, the presence of mitochondria, comparing proximal
with distal axons, should be evaluated.
In any case, motor axon degeneration represents a dominant
effect compared with the loss of cell bodies in the course
of ALS. Similarly, the ultimate anatomical target to promote
neuroprotection in ALS shifts from the spinal cord to the muscle.
This leads to focus on diverse motor neuron compartments
(primarily distal axons compared with proximal axons, cell body,
and dendrites).
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Therefore, in the present study ultrastructural morphometry
of compartment-dependent mitochondrial alterations occurring
in G93A mice was carried out. In detail, we used quantitative
ultrastructural morphometry to count mitochondrial alterations
occurring at the level of dendrites, neuronal cell bodies, and
motor axons. This latter compartment was further evaluated
to measure mitochondrial alterations within distal compared
with proximal axons. We examined at transmission electron
microscopy (TEM) changes of mitochondrial size, amount,
distribution, and mitochondrial alterations involving selective
organelle architecture and swelling. Moreover, to understand the
phenomena of axonal degeneration beyond mitochondrial level
we investigated the fine ultrastructure of additional sub-cellular
components within ALS proximal and distal motor axons. This
was measured both in baseline conditions, in G93A SOD-1
transgenic mice compared with wild types, and following lithium
to produce autophagy stimulation (Sarkar et al., 2005; Sarkar
and Rubinsztein, 2006; Fornai et al., 2008a; Pasquali et al., 2010;
Klionsky et al., 2012; Motoi et al., 2014). In fact, lithium is known
for a long time as a mood stabilizer and it was recently shown to
possess neuroprotective effects in various degenerative disorders,
including those affecting motor neurons (Madeo et al., 2009;
Luo, 2010; Shimada et al., 2012; Chiu et al., 2013; Agam and
Israelson, 2014; Lieu et al., 2014; Mohammadianinejad et al.,
2014; Motoi et al., 2014; Yáñez et al., 2014; Dwivedi and Zhang,
2015). This is in line with recent data showing that all autophagy
inducers being tested so far protect in ALS experimental models.
This is the case of rapamycin (Wang et al., 2012; Cheng et al.,
2015), trehalose (Schaeffer et al., 2012; Castillo et al., 2013; He
et al., 2015), resveratrol (Han et al., 2012), spermidine (Wang
et al., 2012), tamoxifene (Wang et al., 2012), carbamazepine
(Wang et al., 2012), valproate (Boll et al., 2014; Wang et al.,
2015), histone deacetylase 6 (Chen et al., 2015), food starvation
(Wiesner et al., 2015). This was also achieved by increasing
expression of autophagy activating genes (Hetz et al., 2009;
Oliván et al., 2015; Yang et al., 2015). Lithium administration
may not induce autophagy if lithium plasma levels are way below
those required to stimulate the autophagy pathway and produce
any therapeutic effect (Pizzasegola et al., 2009; Chiu et al.,
2013). Since, lithium-induced ultrastructural changes produce
marked effects on mitochondria, involving size, shape, number
and architecture, we further detailed these effects in vitro in
cell lines to reduce experimental variables. In these experimental
conditions, we could replicate the effects observed ex vivo in the
spinal cord and we set up the ultrastructural measurement of
mitochondriogenesis. In particular, we wish to provide for the
first time in situmorphological evidence formitochondriogenesis
by high resolution (TEM) autoradiography of [2-3H]adenosine.
MATERIALS AND METHODS
Ex Vivo Study
Animals
Male B6SJL-TgN (SOD1-G93A)1 Gur mice, expressing human
G93A SOD-1 mutation (N = 10) and wild type (WT) littermates
(N = 10) were purchased from the Jackson Laboratory
(Bar Harbor, ME, USA) via Charles River (Calco, LC, Italy).
Mice received food and water ad libitum and were housed
under controlled conditions: 12 h light/dark cycle, 21◦C room
temperature.
This study was carried out in agreement with the European
Council directive (86/609/ EEC). The experiments were approved
by the Ethical Committee at the University of Pisa (protocol n.
14540, November, 21st, 2011).
Experimental Groups and Treatments
Transgenic G93A SOD-1 mice and their WT littermates were
divided into four experimental groups: lithium-treated G93A
mice (N = 5); vehicle (saline, sodium chloride 0.9%)-treated
G93A mice (N = 5); lithium-treated WT mice (N = 5) and
vehicle-treated WT mice (N = 5). All treatments started at
67 days of age, which corresponds to a pre-symptomatic stage,
and they were carried out every other day up to a tetraplegic
stage (end point), whenmice were sacrificed with deep anesthesia
(chloral hydrate). The tetraplegic stage was defined when mice
were no longer able to get up from a lying position within a 30 s
time interval (Parone et al., 2013; Fornai et al., 2014). This end
point was chosen in order to avoid discomfort due to impaired
feeding, drinking and breathing (Tankersley et al., 2007; Fornai
et al., 2014). Lithium chloride (Sigma, St. Louis, MO, USA)
was administered (both to G93A and WT mice) at the dose of
1mEq/Kg, i.p. dissolved in 200µl of saline. All treatments were
carried out between 9.00 and 12.00 am.
Transmission Electron Microscopy of Spinal Cord
and Muscle
Following deep anesthesia mice were trans-cardially rinsed with
saline solution (0.9%) and they were fixed by perfusion with
2% paraformaldehyde/0.1% glutaraldehyde in 0.1M phosphate
buffered saline, pH = 7.4. The spinal cord and gastrocnemius
muscle were dissected. Spinal cords were kept overnight at 4◦C
in situ using the same fixing solution.
Specimens from Spinal Cord
The lumbar tract of the spinal cord was surgically dissected
to avoid any abnormal pressure and post-fixed in a 1% OsO4
buffered solution for 1 h and 30min, and dehydrated in ethanol,
and embedded in Epon-araldite.
For each spinal cord sample two tissue blocks (volume
of 5mm3) were cut to obtain an average of 20 grids. Each
grid included at least 5 cells, which were analyzed along non-
serial sections. Motor neurons were selected based on classic
morphological features (multipolar cells with dispersed nuclear
chromatin and prominent nucleoli). In order to improve the
selection of motor neurons we also applied a size exclusion
criterion. This consists of excluding from counts those lamina
IX neurons measuring less than 30µm of maximum diameter.
This limits the analysis to phasic alpha motor neurons ruling out
gamma motor neurons and most tonic alpha motor neurons, but
it guarantees to rule out type I Golgi projecting neurons. This
size-exclusion criterion is validated by several previous studies
adjusted to various mouse strains (Morrison et al., 1998; Martin
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et al., 2007; Fornai et al., 2008a, 2014; Ferrucci et al., 2010; Fulceri
et al., 2012).
Morphometry of motor neurons was carried out by using
TEM at 8000x magnification. Specimens form spinal cord were
used to analyze proximal motor axons and glial cells surrounding
motor neurons in the ventral horn.
Specimens from Muscle
Each gastrocnemius muscle from each animal was dissected
and gently stretched for 10 s before being immersed for 1 h
and 30min in the fixing solution used for perfusion. Samples
were then post-fixed in buffered 1% OsO4 for 1 h and 30min,
dehydrated in ethanol and processed as described above. To
guarantee a homogeneous analysis of the same muscle area in
each mouse, we cut little blocks in the central part of the belly
at the level of the wider muscle size each measuring a volume
of 5mm3. Since various muscle fibers orientation may lead
to different structural perspectives and different measurements,
each block was cut following the same longitudinal orientation.
This procedure allows to keep constant the reference points and
to follow the course of peripheral nerve fibers within muscle
length allowing to reduce as much as possible experimental bias.
Analysis at TEM was oriented by a previous light microscopy
observation on 1–2µm thick serial semi-thin sections, which
were cut using a Porter Blum MT-1 or an ultramicrotome
Reichert-Jung. These slices were stained with 1% toluidine blue
and 1% methylene blue in 1% sodium tetraborate and they were
analyzed to verify homogeneity of muscle segments and nerve
fiber tracts.
Analysis of gastrocnemius muscle and peripheral nerve fibers
was carried out by using TEM at 2500–6000x magnification.
Muscle architecture was examined as follows: (i) intersarcomeric
area, defined by the space intermingled between two sarcomers;
(ii) density of mitochondria in the muscle, defined by the
number of mitochondria per surface unit; (iii) percentage of
altered mitochondria; (iv) mitochondrial diameter; (v) diameter
of sarcoplasmic reticulum cisternae.
In peripheral nerve fibers the following parameters were
analyzed: (i) density of mitochondria; (ii) percentage of altered
mitochondria (defined below); (iii) mitochondrial diameter; (iv)
axons owing enlarged and/or fused myelin layers.
Analysis of Mitochondrial Alterations
Mitochondria were defined as altered according to criteria being
validated by previous morphological studies (Ghadially, 1988;
Fornai et al., 2008a; Lenzi et al., 2012) as follows: (i) significantly
decreased electron density of the matrix (dilution, vacuolization,
cavitation); (ii) fragmented and ballooned cristae (intracristal
swelling); (iii) partial or complete separation of the outer
and inner membranes; (iv) mitochondrial swelling. This latter
criterion allows to distinguish mitochondrial enlargement which
might develop in physiological conditions from pathological
swelling which appears as an increase in mitochondrial size due
to a swelling of the mitochondrial structure.
Accordingly, the following data were calculated: (i) density
of mitochondria in dendrites; (ii) density of mitochondria in
the cell body; (iii) density of mitochondria in proximal and
distal motor axons; (iv) percentage of altered mitochondria
in dendrites, cell bodies, and motor axons; (v) mitochondrial
swelling in dendrites, cell bodies and proximal and distal motor
axons.
Additional Morphometric Analysis
In order to document ultrastructural alterations other than
mitochondrial changes we analyzed the following: (i) dendrites
diameter; (ii) ultrastructure of glial cells; (iii) clogging of
motor axons. This was measured both as the percentage
of clogged axonal area and percentage of motor axon with
total clogging. Clogged motor axons were defined as axons
filled with an electron-dense compact material in which
membranes, mitochondria, and neurofilaments were no longer
distinguishable but jamming in the axoplasm. Total clogging
was defined by a condition in which axoplasm was no longer
visible in the ultra-thin section due to the total filling with
such electron-dense compact material. In some cases, the
concomitant disarrangement of myelin sheet led inner myelin
layers to project within axoplasm, thus contributing to axonal
clogging.
In order to document the autophagy status, we analyzed
double and multiple membranes vacuoles. This was done to
confirm the occurrence of big stagnant autophagy vacuoles in
ALS mice and their removal following lithium. These vacuoles
were further identified by immunogold particles staining for LC3
and beclin-I according to the gold standard procedure to identify
autophagy vacuoles.
For immuno-electron microscopy we did not apply the
routine method, consisting of acrylic resins for embedding,
since this procedure preserves antigens but impairs preservation
of the fine morphological architecture (Lenzi et al., 2012).
Thus, samples were embedded in Epon-araldite, as previously
described, and incubated for 24 h at 4◦C with primary antibodies
anti-beclin-I (Santa Cruz Biotechnology Inc., Dallas, TX, USA,
diluted 1:10) and LC3 (Santa Cruz Biotechnology Inc., diluted
1:10) in a buffer solution (PBS, 1% goat-serum, and 0.2%
saponin). After washing in phosphate buffer, sections were
incubated with gold-conjugated secondary antibodies (with gold
particles averaging 10 nm for beclin-I and 20 nm for LC3,
respectively, Sigma) diluted 1:20 in PBS for 1 h, at room
temperature. This allowed co-staining for both antigens. Finally,
sections were fixed with 1% glutaraldehyde and stained with
uranyl acetate and lead citrate and they were examined under
TEM. Control sections were not exposed to the primary antibody
but they were directly incubated with the secondary antibody.
This immunocytochemistry was aimed at specific recognition of
autophagy vacuoles, therefore no quantitative measurement of
immunogold particles was carried out.
On the other hand, immunocytochemistry for mitochondrial
SOD-1 (Assay Designs, Ann Arbor, MI, USA, dilute 1:10)
was carried out for quantitative purposes. SOD-1 was revealed
stoichiometrically by immunogold particles (10 nm, Sigma). The
count of particles localized within mitochondria was obtained
from two plastic blocks randomly chosen from each experimental
group. Immunogold particles were counted at TEM with a
magnification of 15,000x.
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Statistics for Ex Vivo Studies
Values were expressed either using the absolute value or as
percentage of normal numerical distributions. Data are reported
as the mean or the mean percentagee ± S.E.M. This was carried
out for altered mitochondria, SOD-1 immunogold particles or
cloggedmotor axons. Inferential statistics to compare groups was
carried out by using One-way analysis of variance, ANOVA, with
Sheffè’s post-hoc analysis (H0 probability was rejected when less
than 5%, P ≤ 0.05).
We wish to emphasize here the need of calculating
mitochondrial density (the number of mitochondria per surface
unit expressed in µm2). In fact, the rough number of
mitochondria within compartments of motor neuron may
introduce experimental bias, since both disease and treatment
modify motor neuron diameter (Martin et al., 2007; Fornai et al.,
2008a), which in turn could bias the mitochondrial count (which
could be either diluted or concentrated). Again, despite size
exclusion criteria, different sizes between various compartments
would not be comparable. This also applies to measurement
carried out within muscle fibers. Changes in mitochondrial
volume were considered separately from mitochondrial swelling
which was a pure mitochondrial damage.
In Vitro Studies
Primary Spinal Cord Cultures
Mixed primary cell cultures from spinal cords were obtained
from 14-days-old mice embryos as previous described (Carriedo
et al., 1996). Pregnant (14 days gestation) Swiss Webster female
albino mice were purchased from Charles River Laboratories
(Calco, Lecco, Italy). The spinal cords were dissected and both
meninges and dorsal root ganglia were removed. The cords were
then incubated for 10min in 0.025% trypsin and cells were
dissociated. The cell cultures were plated at a density of 3 “spinal
cords” per well plate (35mm dishes) on poly-D-lysine-coated
glass coverslips and maintained in D-MEM supplemented with
5% FBS and 5%HS. Twenty-four hours after plating, the medium
was replaced with Neurobasal supplemented with B-27 and
0.5mM glutamine. Three days after plating cytosine arabinoside
(10µM) was added and medium was changed every 3 days.
For analysis at light microscopy, cells grown on glass coverslips,
within 35mm diameter dishes, and they were transferred into
cell culture plates 24 well, to perform immunohistochemistry for
SMI32.
Spinal cord cultures at 8–9 days were used for toxicity
experiments. The cells were administered the autophagy blocker
3-methyladenine (3-MA) 5, 10, and 20mM for 4 h with or
without lithium chloride at the dose of 0.5 mEq/L. After this
time, the cultures were rapidly washed and maintained in the
free medium with lithium or vehicle for 24 h. To identify motor
neurons, immunocytochemistry for SMI32 was performed on
primary cultures. At first, cells were fixed in a solution containing
4% paraformaldehyde in 0.1M PBS, pH 7.3 (10min); after
washing in PBS cell cultures were incubated with Triton-X 0.1%
in PB (15min), followed by 3% hydrogen peroxide (10min).
Before incubation with the primary antibody, a blocking solution
(10% normal goat serum in PBS) was added for 1 h at room
temperature. The SMI32 primary antibody (mouse, 1:1000;
Covance, Emeryville, CA, USA) was dissolved in PBS containing
2% normal goat serum and incubated overnight at 4◦C. After
rinsing in PBS the anti-mouse secondary biotinylated antibody
(Vector Laboratories, Burlingame, CA USA) was used at a
dilution of 1:200 for 1 h at room temperature, followed by
incubation with ABC kit (1 h at room temperature, Vector
Lab) and diaminobenzidine (Vector Lab). Immunostaining was
analyzed at light microscopy (Nikon Eclipse 80i, Japan).
The effects of each treatment on the survival of motor neurons
were measured by counting the number of SMI32 positive motor
neurons in a total of 3 slides per group. All measurements
were carried out at 20x magnification. Values are given as the
percentage mean ± S.E.M. Comparisons between groups were
made by using ANOVA with Sheffè’s post-hoc analysis.
Cell Lines
PC12 cells were obtained from the American Type Culture
Collection and they were grown in RPMI 1640 medium
supplemented with 10% heat-inactivated horse serum, 5%
fetal bovine serum, penicillin (50 IU/mL), and streptomycin
(50mg/mL). Cells were seeded in 6-well plates at 1 × 106 cells
in a final volume of 1ml/well and incubated at 37◦C in 5% CO2
for 24 h.
PC12 cells were treated either with lithium chloride (1mEq/L
for 48 h) which was dissolved in culture medium (3ml per
dish) or they were added 3ml of plain culture medium
(controls). When studied for autoradiography both groups
of cells received 1µCi of [2-3H]adenine for 2 h, starting
at 46 h after lithium/medium administration. Both lithium
concentration, and the amount and time of exposure to [2-
3H]adenine were selected based on pilot studies. [2-3H]Adenine
(15-25 Ci mmol−1) was purchased from the Radiochemical
Centre (Amersham, Bucks, UK). L4 photographic emulsion
for electron microscopy autoradiography was obtained from
Ilford (UK). In addition, plain ultrastructural morphometry (no
autoradiography) was carried out from PC12 dishes which were
treated with lithium or plain culture medium but they were
not exposed to [2-3H]adenine. This was necessary to avoid that
electron density of [2-3H]adenine impairs the fine morphometry
of mitochondria and other organelles.
Cells were centrifuged at 1000 g for 5min. After removal
of the supernatant, each pellet was thoroughly rinsed in PBS.
Fixation was carried out with a solution containing 2.0%
paraformaldehyde/0.1% glutaraldehyde in 0.1M PBS (pH 7.4) for
90min at 4◦C. Specimens were post-fixed in 1% OsO4 for 1 h
at 4◦C, dehydrated in ethanol and embedded in Epoxy-resin.
For routine TEM, ultrathin sections were contrasted with uranyl
acetate and lead citrate, and examined using a Jeol JEM SX 100.
For ultrastructural morphometry, sections were examined
directly at TEM at a magnification of 6000x. Each grid containing
enough non-serial sections to count at least 50 cells. Several grids
were observed in order to obtain a total number of at least 200
cells for each experimental group. For routine microscopy, the
total number of mitochondria per cell, the number of altered
mitochondria and their diameter was also measured. The altered
mitochondria were described as mentioned above for ex vivo
samples according to Ghadially (1988).
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For electron microscopy autoradiography, ultra-thin sections
were collected on Formvar-coated nickel grids and mounted
on cork caps made adhesive with double-sided sticky tape. A
monolayer of jellified Ilford L4 emulsion was then placed onto
the nickel grids firmly held by the cork caps using a 2 cm wide
platinum wire loop. They were then placed in black light tight
boxes and exposed for up to 30 days at 4◦C in a dry environment.
By the end of this period, the emulsion over the grids was
developed in D19 developer, fixed and thoroughly washed in
distilled water.
The number and size of silver grain clusters were carefully
calculated in each cell. In particular, their distribution in nuclear
and cytosolic compartments was distinguished. Autoradiography
grains as following: (i) number of grain clusters placed within
or close to mitochondria up to 250 nm distance between the
cluster contour and the closest mitochondrial outer membrane;
(ii) diameter of grain clusters placed within or close (up to
250 nm distance) mitochondria (defined as previously); (iii)
ratio between grain clusters placed within or close (up to
250 nm distance) to mitochondria and total grain clusters in the
cytoplasm.
We counted a total of 20 cells per group. Comparisons
between groups were made by using ANOVA with Sheffè’s post-
hoc analysis to compare various distances from mitochondria.
Data were analyzed using Student’s t-test for unpaired data when
two groups at a single distance were compared.
As for ex vivo studies, we calculated both the total
number and percentage of altered mitochondria. Due to
a lack of dendritic/somatic/axonal compartments in PC12
cells and homogeneous diameter of the cell line, we did not
find any significant difference in providing mitochondrial
data as expressed in rough number or in density. In
contrast, when analyzing autoradiography data it was
essential to compartmentalize morphometrical calculation
of autoradiography grains based on their distance from
mitochondria. In detail, the distance of 250 nm was selected as
the critical length for which the highest difference was observed
between lithium and vehicle-treated cells. At this distance, in
lithium treated cells the number of grain clusters was the highest
and it does not differ significantly from the number of grain
clusters counted on the mitochondrial surface (Figure 1). We
counted cytoplasmic grain clusters placed both on mitochondria
and at different lengths from mitochondrial contour. This was
done at progressive (100 nm) distances. Grain clusters were
counted within homogeneous areas which corresponded to
squares measuring 100 nm side. Under lithium administration
these measurements were homogeneous within mitochondria
and within an area which was distant 250 nm from the outer
mitochondrial membrane. After the critical length of 250 nm,
clusters which were counted within squares at progressive
100 nm distance possessed a number of grain clusters which
decreased geometrically. In this way we sought to determine
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FIGURE 1 | Compartmentalization of autoradiography grain clusters. Cytoplasmic grain clusters are counted in the presence of lithium (squares-labeled curve)
or vehicle only (circles-labeled curve). Grain clusters express the presence of [2-3H]adenine within mitochondria (X = 0) and at various distances from the
mitochondrial outer membrane which was expressed in nm (X = Nnm). The number of grain clusters for each X-value is reported on the Y axis. Grain clusters were
counted within homogeneous areas which correspond to squares measuring 100 nm side. Under lithium administration these measurement were homogeneous
within mitochondria and within an area which was distant 250 nm from the outer mitochondrial membrane. After the critical length of 250 nm, squares counted at
progressive 100 nm distance possessed a number of grain clusters which decreased geometrically. Each point reports the mean ± S.E.M. of clusters. This generated
a highly polarized distribution. In contrast, when cells were administered vehicle, the number of grain clusters was distributed quite homogeneously with no significant
difference. This indicates that lithium produces a source of autoradiography which is centered on mitochondria according to the model published by Salpeter et al.
(1978). For each point values represent the mean ± S.E.M. Comparisons between points were made by using ANOVA with Sheffè’s post-hoc analysis. *P ≤ 0.05
compared with control.
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whether a theoretical source of autoradiography could be
identified at mitochondria. In fact, assuming that [2-3H]adenine
binds to novel synthesized mitochondrial DNA, mitochondria
become the source of autoradiography diffusion according to
the model provided by Salpeter et al. (1978). This assumption
is based on the occurrence of authentic mitochondriogenesis
under the effects of lithium. As reported in Figure 1, for lithium-
treated cells, the number of autoradiography clusters starts to
decrease in areas placed at a distance of more than 250 nm
from mitochondrial contour. In contrast, in vehicle-treated cells
there is no critical length. This demonstrates the occurrence of
a polarization in the distribution of autoradiography clusters,
which occurs only when lithium is present. Thus, squared area
of 100 nm side ranging within mitochondria and around up to
250 nm length frommitochondria, correspond to the critical spot
in which the difference in the number of autoradiography clusters
reaches the maximal polarization and the maximal difference
between lithium and vehicle treated cells. This starting point
pertains to methodology while providing already experimental
data speaking out for in situ evidence of mitochondriogenesis
induced by lithium. The occurrence of nuclear staining was
clearly independent from mitochondria (ranging way in excess
of 250 nm and it was bound to nuclear DNA). Of course this
staining does occur but it does not interfere with the count in
the cytosol where the staining was really scarce at distance from
mitochondria. Thus, two sources of radioactive staining occur:
(i) nuclear chromatin; (ii) cytosolic mitochondria. Nuclear and
cytosolic compartments are generally separated one from each
other by large areas of faint randomly placed staining, which is
similar to the loss of radioactivity occurring in the cytosol for
areas placed between mitochondria. When a mitochondrion
was placed at a distance not exceeding 250 nm from the nucleus
(less than 10% of mitochondria) this was not included in the
count. This was done to avoid bias of contaminating counts with
the nuclear source of clusters. The cluster density we counted
within mitochondria corresponds to that measured within a
250 nm range from mitochondrial contour. This explains graph
in Figure 1 where the Y-values of radioactive clusters was
constant in the interval between X = 0 (corresponding to the
mitochondrial surface) and X = 250 nm. When counts were
carried out in space intervals extending above 250 nm, at 100 nm
progressive intervals we measured a geometric fall in the number
of clusters (Figure 1). This curve of cluster distribution produced
by lithium was abolished in vehicle-treated cells.
RESULTS
Morphometry of Mitochondria within Cell
Bodies of Motor Neurons, Lithium–and
Disease-modifying Effects
Figure 2A shows representative semi-thin sections from the
anterior horn of WT and G93A mice treated either with
vehicle or lithium. It is evident the general shape of motor
neurons which appear as multipolar cells, in which nucleus
is not condensed and the nucleolus is well evident. The size
of motor neurons corresponds to the size exclusion criterion.
Nonetheless, in these representative pictures we reported the
disease-dependent increase inmotor neuron size (compare G93A
vehicle with WT vehicle) and the effects of lithium, which
brings back motor neuron diameter to control values (compare
G93A lithium with WT vehicle). Interestingly, as we already
published (Fornai et al., 2008a), the size of motor neurons in
WT is further decreased by the effects of lithium. This size
change does not exceed 10% of diameter and it does not affect
significantly the size exclusion criterion. In addition, within
motor neurons of G93A mice a prominent vacuolization is
evident which is markedly reduced by lithium administration
(Figure 2A). These semi-thin sections addressed further studies
at electron microscopy reported in representative Figure 2B
showing well-shaped and regularly-sized mitochondria in WT
mice compared with swollen mitochondria of G93A mice, which
possess matrix dilution and breaking of the cristae. This is
further documented in Figure 3 showing swollen mitochondria
with fragmented and swollen cristae with a rupture of both
inner and outer membranes. Remarkably, mitochondria from
ALS mice are abnormally swollen up to an average diameter
which is way in excess to what it was measured in WT
mice (0.69 ± 0.05 and 0.38 ± 0.025 respectively, Figure 4).
These altered mitochondria often appear within autophagy
vacuoles which are identified by the gold standard procedure
according to Klionsky et al. (2012) as TEM-identified double
membrane organelles (Figure 3A), staining both for LC3 and
beclin I (Figure 3B). In these mice, the amount of giant/altered
mitochondria, which was found within big stagnant autophagy
vacuoles, was very high (percentage of 75.25 ± 3.1 %, Figure 4).
As shown in Figure 2B, the mitochondrial alterations were
reduced by lithium, thus providing a gold standard TEM
validation for lithium-induced autophagy. In detail, as counted in
graphs of Figure 4 lithium increases the density of mitochondria
(Figure 4A), it reduces the amount of altered mitochondria
(Figure 4B), and it reduces mitochondrial diameter (both in
normal and swollen mitochondria, Figure 4C). Thus, in ALS
mice administered lithium for about 170/180 days we found
a marked suppression of giant swollen mitochondria with
slighter matrix dilution and rare cristae fragmentation. These
mitochondria were barely detectable within autophagy vacuoles,
which in turn did not appear as big stagnant vacuoles but they
were similar to controls.
Morphometry of Mitochondria within
Motor Neuron Dendrites, Lithium–and
Disease-modifying Effects
Dendrites were partly reminiscent of what we already described
within the neuron cell body (Figure 5). However, a striking
effect concerns dendritic volume. G93A mice possess giant
dendrites compared with WT mice as evident in representative
pictures and in graph of Figure 5A.This effect is way more
pronounced of what already described for the cell body
of motor neurons. This explains why, despite an increase
in the total number of mitochondria the density of these
organelles was attenuated in the dendrites of G93A mice
(Figure 5B). In detail, mitochondrial morphology was deranged
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FIGURE 2 | Representative pictures at light microscopy and transmission electron microscopy of motor neurons. (A) Semi-thin sections are obtained from
lamina IX region of the anterior horn of mice spinal cord stained with methylene and toluidine blue. In WT and G93A mice motor neurons appear as multi-polar cells,
where the nucleus is not condensed and the nucleolus is well-evident. Motor neurons were chosen also according to a size exclusion criterion as reported in the
Materials and Methods. The size of motor neurons increases in G93A mice administered vehicle. In this group the cytoplasm is filled with large vacuoles (arrows).
Following lithium administration, large vacuoles disappear. (B) Motor neurons in the anterior horn were analyzed for TEM ultrastructural morphometry of mitochondria.
Mitochondria from WT mice treated with vehicle are regularly shaped with homogeneous matrix. In this group only a few mitochondria possess slightly ballooned
cristae (arrows). This architecture is further improved by lithium administration, which increases electron-density of the matrix and the integrity of the cristae. In G93A
mice administered vehicle, mitochondria exhibit a partial (arrows) or total (#) matrix dilution and dramatic fragmentation of the cristae (arrowhead). Remarkably, in
G93A mice lithium reverses mitochondrial alterations leaving only a few altered mitochondria (arrows). N, nucleus. Scale bars = (A) = 30µm; (WT vehicle) = 0.46µm;
(WT lithium) = 0.30µm; (G93A vehicle) = 0.60µm; (G93A lithium) = 0.5µm.
in G93A mice compared with WT. These effects were prevented
by lithium, which produces a mitochondrial morphology
similar to WT both concerning the architecture and diameter
of dendritic mitochondria (Figures 5C,D). Lithium further
augmented mitochondrial number but this effect was mitigated
by the measurement of mitochondrial density (which is in line
with the giant dendritic volume of G93A mice). When lithium
was administered to WTmice an improvement of mitochondrial
architecture and increase inmitochondrial density were observed
(Figure 5). The percentage of altered mitochondria, which was
significantly higher in G93A mice administered vehicle, was
brought back to WT values following lithium administration
(Figure 5C).
Morphometry of Mitochondria within
Proximal Motor Axons, Lithium–and
Disease-modifying Effects
When observing representative pictures of motor axons, in
G93A mice (Figure 6) dramatic mitochondrial alterations were
evident which surpassed those described for mitochondria in the
cell body and dendrites of motor neurons. Severe architectural
alterations of mitochondria were fairly prevented by lithium
(Figure 6).
Unexpectedly, while lithium increases the density of
mitochondria in the cell body (Figure 4A) this does not occur
within proximal axons where the density of mitochondria
in G93A and WT mice treated with lithium was reduced
similarly to G93A mice treated with vehicle (Figure 6A). Thus,
within proximal axons lithium and the disease condition
independently produce a similar mitochondria reduction
(Figure 6A). However, altered mitochondria were markedly
suppressed by lithium administration of G93Amice (Figure 6B).
The percentage of altered mitochondria in the proximal axon
was similar to that counted in the cell body. This is corroborated
by representative pictures, which demonstrate mitochondrial
impairment in proximal motor axons (see insert of Figure 6).
However, in the proximal axon there is a significant decrease
in the total number of mitochondria which does not occur in
the cell body. This suggests that disease progression leads to a
similar mitochondrial damage in the cell body and proximal
axons but the number of mitochondria is frankly diminished
only in the proximal axon. Interestingly, this effect was observed
also in G93A mice administered lithium and, most remarkably
it was measured in lithium-administered WT mice. One might
argue that this count is explained by the lack of mitochondrial
replacement (likely sustained by mitochondriogenesis) within
proximal axons both in disease conditions as well as under
accelerated mitophagy promoted by lithium. Noteworthy,
the few mitochondria counted both in G93A and WT mice
treated with lithium appear to be structurally preserved
(representative pictures of Figure 6). This is confirmed by
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 November 2015 | Volume 9 | Article 434
Natale et al. Compartmentalized mitochondria, mitophagy, and mitocondriogenesis in ALS
FIGURE 3 | Representative electron micrographs from G93A mice. These pictures show at high magnification motor neurons from vehicle-treated G93A mice.
These neurons possess a cytoplasm filled with large, stagnant autophagy vacuoles (thick arrows). Vestigial mitochondrial cristae (thin arrows) are present in a
multiple-membranes autophagy vacuole (A). Two degenerated mitochondria, wrapped by a close autophagy vacuole (arrowheads), show ballooned cristae, and
breakings of outer and inner membranes (#). LC3 (thick arrows) and beclin-I (thin arrows) immunogold particles are closely associated with autophagy membranes
thus witnessing as the established gold standard to identify autophagy vacuoles (B). M, mitochondria. Scale bars = (A) = 0.53µm; (B) = 0.39µm.
counts of altered mitochondria and mean mitochondrial
diameter within motor axons (Figures 6B,C). Moreover, one
should consider that, when counting mitochondria at this
proximal level within the cord or in the ventral root as carried
in this paragraph and in the work by Parone et al. (2013),
this does not necessarily reflect the mitochondrial status at
distal axons where the critical damage occurs. This is the first
time, which a separate count for axonal mitochondria, was
carried out to distinguish what occurs in the proximal axons
compared with peripheral axon which is reported in the next
paragraph.
Morphometry of Mitochondria within Distal
Axons, Lithium–and Disease-modifying
Effects
The morphometry of distal axons reveals remarkable differences
compared with proximal axons. As shown in representative
pictures of Figure 7 the mitochondrial damage is further
worsened in vehicle-administered G93A mice compared with
every other compartment including proximal axons.
The axoplasm of distal axons is entirely jammed by
abnormal structures where normal constituents are no longer
distinguishable (see next paragraph). These abnormal structures
include the myelin sheet, which seems to intrude the axoplasm
itself and is altered (see insert). This is reverted by lithium.
In fact in the peripheral axons the loss of mitochondria is
prevented by lithium which increases mitochondrial number
similarly to WT mice (Figure 7A) Lithium also provides
significant protection against mitochondrial damage which is
mostly evident in G93A mice administered vehicle (Figure 7B).
The amount of mitochondrial damage measured in the distal
axons involves almost the total number (more than 90%).
This implies that preserved mitochondria in the distal axons
are more than two-fold the preserved mitochondria within
proximal axons, where only a subtotal (less than 80%)
mitochondrial damage takes place (compare Figure 7B with
Figure 6B).
These data fully confirm the occurrence of the worst
mitochondrial damage in peripheral axons as described also in
ALS patients (Shi et al., 2010).
These data indicate the need to extend the ultrastructural
morphology of ALS axons toward the peripheral segments to
unravel the significance of axonal compared with perikaryal
alterations. This is reciprocated by the occurrence of protective
effects of lithium both on mitochondrial density (Figure 7A),
and mitochondrial alterations (Figure 7B). At this level, lithium
reduced mitochondrial diameter due to a specific effect on
preventing mitochondrial swelling (Figure 7C).
Extra-mitochondrial Morphometry of
Axons, Lithium–and Disease-modifying
Effects
When observing the extra-mitochondrial alterations within
motor axons (Figure 8) low magnification provides a clear
perspective of axonal clogging which was further detailed in
previous Figure 7 by abnormal structures, which were jamming
the axoplasm. In G93A mice administered vehicle this effect
leads to electron-dense material which fills almost totally the
axoplasm, which is cleared back significantly by lithium as
shown by representative pictures and graphs of Figure 8. These
jams are clearly visible in the insert at high magnification of
Figure 8 in vehicle-administered G93A mice as mixed structures
clogging the axoplasm. These axonal inclusions are frankly
pathological as witnessed by their amorphous structure and
their total absence in axons from WT mice (Figure 8A). This
contrasts with the occurrence of a critical clogging (more
than 60%) of axoplasm which was present in several motor
axons from G93A mice (Figures 8A,B), while it was limited
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FIGURE 4 | Ultrastructural morphometry of mitochondria within cell
body of motor neurons. The soma (cell body) of motor neurons from the
anterior horn of the mouse spinal cord was counted to establish the density
(A) the alterations (B) and the size (C) of mitochondria. The criteria used to
define a mitochondrion as altered were extensively reported in the Materials
and Methods Section. Mitochondrial density within cell body is dramatically
augmented by lithium administration both in WT and G93A mice (A). In line
with the preservation of mitochondrial architecture observed in Figure 2B,
lithium significantly reduces the percentage of altered mitochondria (B). As
noticed from representative pictures a re-shaping effect of lithium is also
counted The size of mitochondria was increased in G93A mice administered
vehicle but it is brought back to WT values when G93A mice received lithium.
Remarkably, such re-sizing effects of lithium also occur in WT mice, where
lithium further decreases mitochondrial diameter in WT mice (C). Values are
given as the mean ± S.E.M. Comparisons between groups was made by using
One-way ANOVA. *P ≤ 0.05 compared with vehicle-treated mice in graph.
to 26% of the luminal area of a few motor axons in G93A
mice administered lithium (Figures 8A,B). This material we
described here selectively in the motor axon compartment is
likely to produce significant deleterious effects concerning axonal
physiology at least affecting axonal transport which indeed is
functionally impaired (Magrané et al., 2012, 2014). In fact, the
amount of clogged area almost reaches 70% of the axonal area
measured in 2D electron microscopy. The administration of
lithium produces a remarkable effect since it tears down the
clogged area of more than two-fold from 63.58 to 26.56%, which
means a net gain of axonal lumen of more than 50% (Figure 8B).
Incidentally, the clearance induced by lithium of more than
two-fold the clogging of motor axons is similar to the increase in
mitochondrial density and the amount of spared mitochondria
(more than two-fold), which was measured in the distal axons.
This indicates that by increasing the available axonal lumen is
associated to the increase of novel mitochondria transported
downstream and the increased number of healthy mitochondria
counted at distal level.
Structure of Muscles, Lithium–and
Disease-modifying Effects
In semi-thin sections from the gastrocnemius muscle (Figure 9)
we could dissect the homogeneous segment to be analyzed
under electronmicroscopy. The severe disarrangement of muscle
structure in vehicle-administered G93A mice is clearly evident
(Figure 9). Similarly, the re-alignment and the lack of abnormal
architecture of muscle fibers can be appreciated in Figure 9
showing G93A mice administered lithium.
When examined at TEM, representative pictures of Figure 10
show that, within muscle fibers from saline-administered G93A
mice, there was a severe loss of the normal sarcomeric structure
as well as the regular alignment of sarcomers. These muscle
fibers from vehicle-administered G93A mice could no longer
be recognized as composed of sarcomeric units. The severe
disarrangement which appears in G93A mice was measured by
counting the distance between vestigial sarcomers (Figure 10A)
which was increased more than ten-fold compared with WT. In
these muscle fibers the effects of lithium were most remarkable
since the intersarcomeric area of lithium-administered G93A
mice was re-instated to values similar to WT. This is well evident
also from representative pictures cited from Figure 10, showing
that lithium substantially preserves the sarcomeric architecture
in the muscle fibers. The fine alignment of sarcomers was even
more geometrically correct when WT mice were administered
lithium, but this pertains only to the appreciation of the pictures
and it was not specifically measured. It is likely that, the density
of mitochondria under the effects of lithium might contribute to
this effect. In fact, when counting the number of mitochondria
in G93A mice a massive decrease was measured, which was
significantly prevented by lithium (Figure 10B). Interestingly,
in WT mice there was a non-significant trend toward a
decrease in the number of mitochondria. In any case dramatic
mitochondrial alterations in the muscle of G93A mice were
totally abolished by lithium administration as can be appreciated
in representative pictures of Figure 11 and as reported by the
counts of graph in Figure 11A. This effect was also evident by
measuring the mitochondrial swelling in each group which was
graphed in Figure 11B as an increase in mitochondrial diameter.
Remarkably, the swelling of sub-cellular structures in the muscle
of G93A mice extends to the sarcoplasmic reticulum which was
increased three-fold compared with wild types (representative
pictures of Figure 11 and graph of Figure 11C). Again, the
administration of lithium abolished such an alteration. Thus,
the preservation of various components of the gastrocnemius
muscle structure was remarkable under the effects of lithium.
This is key, since the loss of muscle structure and architectural
disruption which occurs otherwise in vehicle-administered G93A
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FIGURE 5 | Ultrastructural morphometry of mitochondria within dendrites of motor neurons. Mitochondria within dendrites of motor neurons of the anterior
horn of mice spinal cords are representatively reported. Mitochondria from dendrites of vehicle-treated G93A mice possessed swollen cristae (arrows) which do not
appear neither in WT nor in lithium-treated G93A mice. Low magnification representative picture from vehicle-treated G93A mice shows giant dendrites (arrowhead)
compared with WT mice, this is fully reversed by lithium as counted in graph (A). Graph (B) reports a slight non-significant reduction of mitochondrial density in
vehicle-treated G93A mice compared with WT, which was not affected by lithium. In contrast, altered mitochondria were significantly increased in vehicle-treated
G93A mice compared with WT mice, although lithium treatments restore the percentages of altered mitochondria in G93A to values similar to WT mice (C). The
mitochondrial diameter in dendrites from G93A mice was slightly but significantly increased following vehicle, but it was normal following lithium (D). Values are the
mean ± S.E.M. Comparisons between groups were made by using One-way ANOVA. *P ≤ 0.05 compared with other groups in graph. Scale bars: WT vehicle and
WT lithium = 0.3µm, G93A vehicle and G93A lithium = 0.4µm, G93A vehicle (low magnification) = 1.3µm.
mice along with classic mitochondrial alterations were really
impressive.
In Vitro Study on Cell Lines and Primary
Cultures from Spinal Cord
In order to better document the effects observed in vivo on
mitochondrial morphology and number we measured the effects
of lithium in a PC12 cell line which owns much less experimental
variables. We further extended the mechanistic analysis on the
role of lithium and autophagy in a primary cell cultures from
spinal cord.
As shown ex vivo in the spinal cord, in PC12 line lithium
increases two- fold the number of mitochondria compared with
vehicle (Figure 12A). In this cell line, which owns aberrancies
inherent with their shift from a rat pheocromocytoma (Fornai
et al., 2007) the number of mitochondria, which eventually
undergo spontaneous alterations is noticeable and reaches 15%
of total mitochondria (Figure 12B). These spontaneous
mitochondrial degeneration was suppressed by lithium
administration (which reduced three-fold the percentage of
altered mitochondria, Figure 12B). Thus, considering that
lithium increases two-fold the total number of mitochondria,
while it decreasing three-fold the percentage of altered
mitochondria, the total number of mitochondria which are
structurally preserved by lithium corresponds roughly to six-fold
the number of preserved mitochondria measured in control. At
the same time, lithium reduces significantly the mitochondrial
diameter (Figure 12C). This size reduction was counted
independently from mitochondrial swelling but it was counted
considering only healthy mitochondria. This effect suggests
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FIGURE 6 | Ultrastructural morphometry of mitochondria within proximal axons of motor neurons. Mitochondria within motor axons from the anterior horn
are reported in representative pictures. As it appears in representative pictures mitochondria within motor axons of WT mice treated either with vehicle or lithium
possess well-conformed mitochondria (arrows). In contrast, motor axons from a vehicle-treated G93A mouse possesses dramatic mitochondrial alterations
surpassing those representatively described within the cell body in Figure 2B. These mitochondria possess marked enlargement of the cristae (arrows) and a total
derangement and vacuolization of a mitochondrion (arrowhead). The axonal internal structure shows large vacuoles (#) containing a mitochondrion. Note the vestigial
cristae within vacuolated mitochondrial inner structures (insert). Lithium treatment reduces the severe alterations in axons showing well-conformed mitochondria
(arrow) with some spots of swollen cristae (#). In graph (A) mitochondrial density is markedly reduced in all groups but in WT mice administered vehicle. The
percentage of altered mitochondria (B) and mean mitochondrial diameter (C) which were significantly increased in G93A mice administered vehicle were reduced by
lithium to values compared with controls. Values are the mean ± S.E.M. Comparisons between groups were made by using One-way ANOVA. *P ≤ 0.05 compared
with others groups. **P ≤ 0.05 compared with vehicle-treated WT. Scale bar = 800 nm.
the occurrence of mitochondriogenesis which is known to
produce small densely packed mitochondria with a well-marked
architecture both concerning arrangement of the cristae and
matrix electrondensity. In fact, when observed in representative
TEM pictures (Figure 12), lithium-treated cells consistently
show a dramatic increase in mitochondrial density, which clearly
appears at first glance (see lower magnification in the left row
of Figure 12). At the same time, at higher magnification (in
the right row of Figure 12), the mitochondrial architecture was
well-delineated in lithium-treated cells. These results confirm the
hypothesis that lithium possesses mitochondriogenetic effects.
Based on cell imaging with mitotrack red and green and the
quantitative analysis of mitochondrial genes by rtPCR we already
indicated that lithium induces the biogenesis of mitochondria
(Fornai et al., 2008a). In line with this, a few weeks ago evidence
was provided that autophagy induction is dually bound to
mitophagy and mitochondriogenesis (Palikaras et al., 2015a,b).
However, no single in situ morphological evidence was ever
produced to document the occurrence of mitochondriogenesis
under the effects of lithium. Thus, in the present study we pre-
administered lithium chloride (1mEq/L) or vehicle which was
followed at 48 h by administration of [2-3H]adenine (1µCi).
In these experimental conditions, which follow up experimental
data reported in Figure 1 and already commented in the
Materials and Methods section we studied the distribution of
autoradiography grains. As reported in representative Figure 13,
these grains appeared as electrondense clusters of particles
which were distributed in the cells very differently depending
on exposure to vehicle or lithium. In detail, as shown in
pictures of Figure 13 in a vehicle-administered cell the clusters
distribute quite homogeneously in the cytosol, while a marked
hetereogenity, polarized toward mitochondria was observed in
the cytoplasm following lithium. As reported in Figure 1 this
generates a hot area of [2-3H]adenine clusters which covers all
the mitochondrial surface and the surrounding cytoplasm up to a
250 nm length frommitochondria. In this hot area, measurement
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FIGURE 7 | Representative pictures and morphometry of distal axons. Electron micrographs of cross-sections of myelinated axons. Vehicle- and
lithium-treated WT mice and lithium-treated G93A mice show well-organized myelin sheaths surrounding an axoplasm with normal neurofilaments and well healthy
mitochondria (arrows). In vehicle-treated G93A mice abnormal myelin sheaths, including disruption and disordered arrangement of fibers, are visible. Arrowheads
point to a particular zone of disrupted myelin sheaths with loss of stratification (see also insert). Mitochondrial vestigia (#) are also observed in the altered axoplasm of
G93A vehicle mice. Graph (A) shows a significant reduction of mitochondrial density in vehicle-treated G93A mice compared with other groups. In addition, the
percentage of altered mitochondria (B) and the mitochondrial diameter (C) are significantly increased in G93A vehicle mice. Both effects were prevented by lithium
administration. Values are the mean ± S.E.M. Comparisons between groups were made by using One-way ANOVA. *P ≤ 0.05 compared with other groups. Scale
bars: WT vehicle, WT lithium, G93A vehicle = 0.7µm, G93A lithium = 0.6µm, insert = 0.2µm.
of cluster density in homogeneous areas of squares measuring a
side of 100 nm were similar. At this point, clusters density falls
according to a geometrical distributionwhich confirms themodel
drawn by Salpeter (Salpeter et al., 1978). This represents the
first in situ evidence for lithium induced mitochondriogenesis.
The effects of lithium were evaluated on various patterns of
radioactive grains. Lithium increases the number of grain clusters
(Figure 13A); lithium increases the mean diameter of clusters
(Figure 13B); lithium increases the polarization of cytoplamic vs.
nuclear clusters (Figure 13C); lithium increases the number of
clusters within and immediately around (250 nm) mitochondria
(Figure 13D); lithium increases the ratio between mitochondrial
and scattered cytosolic clusters (Figure 13E). This is in line
with the curve we measured in Figure 1 for [2-3H]adenine
distribution in the cytosol showing that, the distance of 250 nm
corresponds to the critical length for which the highest difference
is observed between lithium and vehicle-treated cells. At this
distance, in lithium treated cells the number of grain clusters is
still the highest and corresponds to the number of grain clusters
counted on the mitochondrial surface. This is clearly visible in
Figure 1 where the Y-values for radioactive clusters counted at
X = 0 (corresponding to themitochondrial surface) was constant
in a range of X = 0–250 nm. This curve of cluster distribution
produced by lithium was abolished in vehicle-treated cells This
indicates significantly the occurrence of mitochondriogenesis
according to the model of Salpeter et al. (1978). As described in
themethod the counts ruled out the staining produced by nuclear
DNA.
In order to further confirm the role of autophagy in motor
neuron survival and the autophagy-dependency of most part
of lithium-induced neuroprotection we analyzed motor neuron
survival in a very controlled experiment where primary motor
neurons from the spinal cord were selectively exposed to an
autophagy inhibitor. As shown in Figure 14, we administered
the autophagy inhibitor 3-MA. When the highest dose of 3-
MA was administered, SMI32 positive motor neurons were
lost dramatically. Thus, in this in vitro model of ALS we
could document autophagy-dependent motor neuron loss which
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FIGURE 8 | Extra-mitochondrial motor axon alterations. WT vehicle- and WT lithium-treated mice show well-conformed myelinated axons (arrows). No
obstructive material is observed within the axoplasm. In contrast, in G93A vehicle-treated mice, axons show an axoplasm filled with an electron-dense,
heterogeneous, condensed aggregated structures clogging the axonal lumen (see detail at high magnification). Lithium treatment reduces the percentage of clogged
motor axons (square), as showed in graph (A). Graph (B) shows the percentage of clogged area within motor axon surface, which appears significantly increased in
vehicle-treated G93A mice, this effect is significantly reduced by lithium treatment. Values are the mean ± S.E.M. Comparisons between groups were made by using
One-way ANOVA. *P ≤ 0.05 compared with other groups. Scale bars: WT vehicle and G93A lithium = 1.5µm, WT lithium and G93A vehicle = 1.8µm. G93A vehicle
(high magnification) = 0.5µm.
was rescued by lithium administration (Figure 14). In these
experimental conditions the subcellular changes replicated those
described in vivo as well as the ultrastructural effects produced
by lithium. Interestingly, as shown in representative pictures and
graph of Figure 15, when we evaluated the immune-electron-
microscopy of the protein SOD-1 we documented the occurrence
of a lithium-dependent clearance of the SOD-1 protein. This
effect confirms the ability of lithium to exert a direct protective
effect at mitochondrial level by removing toxic mutated G93A
SOD-1. Remarkably, while lithium-induced removal of G93A
SOD-1 was significant, no noticeable effect was documented for
WT SOD-1 (Figure 15). Additional effects were produced by
lithium on glial cells as reported in the Supplementary Material
(Figure S1) where lithium which is known to inhibit glial cells
activation still re-shapes mitochondrial size. This effect does not
relate to mitochondrial swelling which we could not document in
glia at significant level.
DISCUSSION
In the present study we compared different motor neuron
compartments in G93A SOD-1 mice. In each compartment
we analyzed the mitochondrial pathology as well as
extra-mitochondrial alterations. These studies were carried out
both in baseline conditions and after autophagy induction in ALS
mice compared with WT. Autophagy was induced by lithium
administration which promoted effective progression of the
autophagy pathway as documented in a variety of experimental
studies as well as in the present work and in the Autophagy
Guidelines by Klionsky et al. (2012). The analysis of motor
neuron compartments was detailed at the level of dendrites, cell
bodies and axons. The axonal compartment was further divided
in proximal vs. distal axons. In this way we wish to evaluate
whether the status of motor axons upstream in the spinal cord
really reflects the ultrastructure of peripheral axons distributed
in the muscle which are known to be early and severely damaged
in ALS. In fact, when we measured mitochondrial alterations
as well as other ultrastructural targets of ALS-related pathology
we documented remarkable differences in distal compared
with proximal axons. These differences are compatible with
the disruption of axonal transport of mitochondria which was
recently described by Magrané et al. (2012, 2014). In keeping
with this, we documented here for the first time, the presence of
axonal jams which clog significantly the axonal lumen suggesting
a morphological correlate for altered mitochondrial transport
along axons (Magrané et al., 2012, 2014). These axonal jams were
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FIGURE 9 | Representative pictures at light microscopy of semi-thin sections from gastrocnemius muscle. Semi-thin sections were stained with methylene
and toluidine blue. Vehicle- and lithium-treated WT mice and lithium-treated G93A mice exhibit longitudinal, regular, parallel arrangement of aligned muscle fibers
showing the typical banding pattern. Nuclei at the periphery of the fibers are visible (arrowheads). Muscle from vehicle-treated G93A mice shows unparalleled and
disarranged fibers and myofibrils. In this latter group the space among fibers appears enlarged (arrow). Scale bar: 28µm.
hardly deciphered in their structure but they appear to contain
mitochondrial remnants as well as proteinaceous aggregates.
Significantly, when G93A mice were administered lithium, this
compound cleared the axonal lumen and produced a significant
improvement of mitochondrial number and morphology which
was much more evident in the distal compared with proximal
segment of the axons. These data confirm the seminal role of
an impairment of autophagy in the progression of ALS. The
occurrence of defective autophagy in ALS was demonstrated
for the first time in the last decade (Fornai et al., 2008a,b).
This was progressively validated through a growing number
of studies (Pasquali et al., 2009; Ferrucci et al., 2010; Otomo
et al., 2012; Shimada et al., 2012; Wang et al., 2012; Castillo et al.,
2013; Ikenaka et al., 2013; Barmada et al., 2014; Cheng et al.,
2015; Lee et al., 2015; Philips and Rothstein, 2015; Xiao et al.,
2015; Yang et al., 2015) up to the very recent confirmative work
by Xie et al. (2015a,b). This evidence was also reviewed in this
issue by Ruffoli et al. (2015). In order to evaluate directly the
significance of impaired autophagy for motor neuron survival, in
the present study we administered the autophagy blocker 3-MA,
which produced a dose dependent motor neuron loss, which in
turn, was rescued by lithium. In the present study we extended
the structural and morphometrical analysis to the gastrocnemius
muscle which possesses dramatic light and electron microscopy
alterations in G93A mice which were reverted by lithium.
While the effects of lithium on motor neuron cell body were
already reported, the occurrence of a remarkable effect in the
distal vs. the proximal axons as well as in muscles was reported
here for the first time in ALS mice. Interestingly, lithium is
known to protect against a variety of peripheral neurophathy as
shown in recent and classic literature. In fact, lithium prevents
peripheral neuropathy induced by paclitaxel (Mo et al., 2012;
Pourmohammadi et al., 2012) as well as the neuropathy induced
by vincristine (Alimoradi et al., 2012) and there is evidence
showing that lithium may even reverse the neurological damage
induced by vinca alkaloids (Petrini et al., 1999). Interestingly,
these compounds are known to inhibit vesicle trafficking, thus
impairing autophagy progression and axonal transport. Again,
in keeping with the dramatic morphological effects of lithium
on peripheral nerves described here, previous studies indicate
that lithium improves peripheral nerve regeneration after injury
(Nouri et al., 2009) and it promotes axonal re-growth after
ventral root avulsion (Fu et al., 2014). Similarly to peripheral
nerves, muscles are known to be significantly affected by lithium
which protects from a variety of degenerative changes such
those occurring after muscle accumulation of amyloid beta and
tau protein and muscle atrophy due to peripheral denervation
(Askanas and Engel, 2008; Du et al., 2008; Kitazawa et al.,
2008; Terracciano et al., 2010; Askanas et al., 2012; Fu et al.,
2014; Su et al., 2014). Additionally lithium promotes myogenic
differentiation and muscle regeneration (Polesskaya et al., 2003;
van der Velden et al., 2007). The amount of muscle protection
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FIGURE 10 | Representative pictures and ultrastructural morphometry from gastrocnemius muscle. Vehicle- and lithium-treated WT mice and
lithium-treated G93A mice show well-arranged mitochondria and myofibrils with the typical pattern of dark and light bands. No ultrastructural alterations were
detected in any of these groups. It is worth of noting that the image from WT lithium-treated mice possess a surprisingly geometrical alignment of sarcomers. Muscle
from vehicle-treated G93A mice shows several disarranged areas with a significant increase in intersarcomeric area (arrows and graph A) containing a few
mitochondria (graph B), these effects being greatly reversed by lithium. Values are the mean ± S.E.M. Comparisons between groups were made by using One-way
ANOVA. *P ≤ 0.05 compared with other groups. Scale bar = 1µm.
observed here along with a remarkable preservation of the
sarcomeric architecture is similar to what demonstrated in these
previous studies carried out administering lithium to muscles
in pathological and baseline conditions. This study provides
the first evidence describing a remarkable protection of muscle
degeneration induced by lithium in the course of motor neuron
disease. The protective effects induced by lithium were analyzed
here by light end electron microscopy and they were measured
by using morphometry of multiple targets within muscle cells.
In fact, following lithium administration the dramatic loss of
alignment of muscle fibers was prevented. Again, the abnormal
inter-sarcomeric area was reduced back to WT values and the
architecture of each sarcomer, which was dramatically altered,
was largely reinstated. Similarly, the abnormal swelling of the
sarcoplasmatic reticulum within muscle fibers from G93A mice
was no longer present when mice were administered lithium.
These effects, which are deeply grounded on the autophagy
stimulating effects of lithium may also depend on a frankly
primary protection by lithium of mitochondrial alterations
such as altered calcium homeostasis. In fact lithium was shown
to mitigate cytosolic calcium elevation (Bosche et al., 2013).
Similarly, as shown by Scheibye-Knudsen et al. (2012), in
the Cockayne syndrome type B mitochondrial protection is
produced when gold standard autophagy activators such as
lithium and rapamycin are administered. In the present study
we did not assess directly potential neuroprotective effects
exerted by lithium on mitochondrial activity; nonetheless
we evaluated whether lithium was able to remove mutated
SOD-1 from mitochondria, which in turn, is considered one
potential mechanism of mitochondrial toxicity in ALS due to a
G93A SOD-1 mutation. Other protective mechanisms exerted
by lithium on mitochondria as a result of lithium-induced
modulation of mitochondrial bioenergetics cannot be ruled out
as convergent mechanisms to produce the overall beneficial
results described here. Since the G93A mouse model is reported
to suffer from an excess of mitochondrial accumulation of
the mutant enzyme G93A SOD-1 within mitochondria, we
evaluated the removal of this enzyme in lithium administered
G93A mice. In fact, we documented in situ by representative
pictures and morphometrical counts the removal of mutant
but not WT SOD-1 in lithium administered G93A mice.
This confirms at mitochondrial level the clearance of SOD-
1 produced by lithium we already reported using western
blotting (Fornai et al., 2008a). The present study provides
significant evidence of a compartment-dependent damage
to mitochondria and other sub-cellular structures in ALS,
while demonstrating the compartment-specific neuroprotective
effects of lithium. The removal of mutant SOD-1 from the
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FIGURE 11 | Representative pictures at high magnification and morphometry of mitochondria and sarcoplasmic reticulum from gastrocnemius
muscle. Vehicle- and lithium-treated WT mice show a normal pattern of mitochondria and sarcoplasmic reticulum (arrows). Vehicle-treated G93A mice show altered
swollen mitochondria (#) with enlarged cristae and sarcoplasmic reticulum with swollen cisternae (arrows); lithium treatment markedly prevents the occurrence of
these ultrastructural alterations (A–C). Values are the mean ± S.E.M. Comparisons between groups were made by using One-way ANOVA. *P ≤ 0.05 compared with
other groups. Scale bar: 0.4µm.
mitochondria of lithium administered G93A mice is expected to
lead indirectly to a preservation of mitochondrial architecture.
This effect which was shown in the cell body of motor neurons
(Figure 15), is still effective in the proximal axons, where it
may contribute to explain why, in the absence of an effective
mitochondrial turnover, the few mitochondria preserve their
structure.
When analyzing at TEM the spinal cord of G93A mice,
mitochondrial swelling and mitochondria-containing large
stagnant vacuoles were measured within motor neuron perikarya
and dendrites of lamina IX. These vacuoles were identified as
authentic autophagy vacuoles by the gold standard (electron
microscopy for multi-membrane vesicles staining both for LC3
and beclin I). Giant swollen mitochondria were characterized by
severe dilution of the matrix and cristae breaking. The increase
in mitochondrial size was dramatic and it was accompanied by
an increase in the amount of altered mitochondria. This was
associated with a dramatic filling with mitochondria-containing
stagnant autophagy vacuoles within cell bodies of motor neurons.
These effects confirm previous findings indicating a defective
autophagy flux in the spinal cord both in ALS patients (Sasaki,
2011) and experimental ALS models (Fornai et al., 2008a;
Li et al., 2008; Xie et al., 2015a,b). In these experimental
conditions we analyzed the effects of a gold-standard autophagy
inducer, which is lithium (Scheibye-Knudsen et al., 2012).
Lithium is known for a long time as a mood stabilizer and
neuroprotective agent (Madeo et al., 2009; Luo, 2010; Shimada
et al., 2012; Chiu et al., 2013; Agam and Israelson, 2014; Lieu
et al., 2014; Mohammadianinejad et al., 2014; Motoi et al.,
2014; Yáñez et al., 2014; Dwivedi and Zhang, 2015) and it
represents a classic autophagy inducer which was validated along
several studies (Sarkar et al., 2005; Sarkar and Rubinsztein,
2006; Fornai et al., 2008a; Pasquali et al., 2010; Motoi et al.,
2014) including the guidelines on autophagy (Klionsky et al.,
2012), which represent the reference point for studies on the
autophagy pathway. We found that lithium administration
reverses/prevents almost completely alterations of mitochondrial
architecture, the occurrence of swollen mitochondria and the
presence of big stagnant autophagy vacuoles. The effects of
lithium on mitochondrial size, shape, number and architecture
are already evident in representative semi-thin sections and they
were quantified by ultrastructural morphometry. Interestingly,
the mitochondrial re-shaping effects produced by lithium were
not limited to diseased motor neurons of G93A mice since we
could document a significant mitochondrial plasticity induced by
lithium even in motor neurons fromWTmice.
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FIGURE 12 | Ultrastructural morphometry of mitochondria in vitro in PC12 cells. Lithium exposure per se significantly increases the total number of
mitochondria (A) and reduces the percentage of altered mitochondria (B). Again, lithium reduces mitochondrial diameter (C). Representative TEM pictures show the
dramatic increase in the number of mitochondria after lithium exposure, which is already evident at low magnification (arrows). In a higher magnification of control
PC12 cell a slight mitochondrial matrix dilution (arrow) is observed; this alteration is no longer present after lithium administration (#). Values are the mean ± S.E.M.
Comparisons between groups were made by using Student’s t-test for unpaired data. *P ≤ 0.05 compared with controls. Scale bars: (low magnification) = 1.45µm;
(high magnification) = 0.14µm.
Interestingly, while in vehicle-administered G93A mice we
never documented the occurrence of small electron-dense
mitochondria, within motor neurons of G93Amice administered
lithium the size of mitochondria was markedly reduced and
these organelles possessed an electron-dense ultrastructure,
which generally corresponds to newly synthesized organelles.
In G93A mice treated with lithium giant mitochondria
were suppressed and the fine mitochondrial ultrastructure
was preserved with slighter matrix dilution and rare cristae
fragmentation being similar to controls. In fact, when counting
mitochondria in both G93A and WT mice treated with lithium
we documented the reduction in mitochondrial diameter, the
increase in mitochondrial electron-density, and the increase
in the total number of mitochondria. These small electron-
dense mitochondria were barely detectable within autophagy
vacuoles. Thus, following lithium mitochondria within cell
bodies of motor neurons increased their number, but they also
preserved a fine architecture and appear as electron dense well-
structured small organelles. These effects are reminiscent of what
happens following mitochondriogenesis. In fact, the stimulation
of the biogenesis of mitochondria as well as mitochondrial
fission increases the number of these organelles. However, when
mitochondriogenesis is increased, the newmitochondria are very
small electron-dense and well-conformed organelles, whereas
the sole fission produces an increased number of mitochondria
which otherwise appear of regular size and conformation. These
data lend substance to what previously documented (Fornai et al.,
2008a,b) suggesting that lithium produces mitochondriogenesis.
In previous studies we provided such an evidence by measuring
quantitative rtPCR for mitochondrial genes or MitoTracker Red
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FIGURE 13 | Representative TEM autoradiographs on distribution of [2-3H]adenine. TEM autoradiographs of PC12 cells exposed to [2-3H]adenine for 2 h.
Grain clusters of [2-3H]adenine are distributed within nucleus and cytoplasm (arrows) of both control and lithium-treated cells. In detail, following lithium administration
grain clusters increase in number (A) and diameter (B) and polarize in the cytoplasm (closer to mitochondria [insert]) (C). To fully consider these data, the reader is
suggested to go back to Figure 1, which demonstrates the significant compartmentalization of grain clusters in the cytosol. In detail, while the total number of grain
clusters in the cells is slightly increased by lithium (A). Such an increase is more pronounced in the cytosol compared with nucleus (C) Within cytoplasm the number of
clusters placed in 100 nm sided squares within or close to mitochondria up to a 250-nm distance from mitochondrial outer membrane, markedly increases after
lithium exposure (D and Figure 1). In fact, in cells treated with lithium within 250 nm there is three-fold amount of grain clusters compared with vehicle treated cells.
The ratio between mitochondrial grain clusters within 250 nm around mitochondria and cytoplasmic grain clusters significantly increases after lithium exposure (E).
Values are the mean ± S.E.M. Comparisons between groups were made by using One-way ANOVA (C) and Student’s t-test for unpaired data (A, B, D and E).
*P ≤ 0.05 compared with control. Scale bars: (low magnification) = 1.1µm; (insert) = 0.43µm.
and Green (Fornai et al., 2008a). This is in line with very
recent data published by Palikaras et al. (2015a,b) showing the
molecular mechanisms which eventually lead to a concomitant
activation of mitophagy and mitochondriogenesis. In detail,
when mitophagy is induced by autophagy activators, a molecular
cascade is triggered which leads to a dual effect inducing
concomitantly the biogenesis of novel mitochondria (Palikaras
et al., 2015a,b).
In order to detail the occurrence of mitochondriogenesis
in situ and to investigate these effects in other cell types,
we measured the effects of lithium chloride in PC12 cells
with or without pre-administration of the nucleotide precursor
[2-3H]adenine in vitro. In this way, despite confirming a
strong mitochondrial plasticity induced by lithium in baseline
conditions, we could document by in situ morphometry that
lithium produces a strong biogenesis of mitochondria as
measured by incorporation of [2-3H]adenine. In detail, the
administration of lithium to otherwise normal PC12 cells
significantlymodifiesmitochondria, which is reminiscent of what
observed ex vivo within motor neurons of WT mice treated
with lithium. In fact, lithium administration further improved
the architecture of mitochondria in PC12 cells. In particular, in
vehicle administered PC12 cells, regularly shaped mitochondria
with a slight degree of matrix dilution were observed.
When PC12 cells were exposed to lithium mitochondrial
morphology was well-defined with increased electron-density
of the matrix and well-defined and densely packed cristae.
Moreover, as described for ex vivomotor neurons’ cell bodies, the
number of mitochondria was dramatically increased following
lithium exposure. This effect also extended to mitochondrial
size, which was decreased by lithium administration. As
previously mentioned, the occurrence at a high rate of
small, well-structured, mitochondria suggests an ongoing
mitochondriogenesis. Therefore, we measured directly in situ,
by using TEM combined with [2-3H]adenine exposure, the
occurrence of mitochondrial DNA replication. In detail, control
and lithium-exposed PC12 cells were examined by high
resolution autoradiography, following administration of [2-
3H]adenine. Under these experimental conditions, radioactive
labeling appears associated both with nucleus and cytoplasm.
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FIGURE 14 | Representative pictures at light microscopy primary motor neuron cultures from spinal cord after autophagy inhibition and stimulation.
Immunopositive SMI32 motor neurons were treated with the autophagy inhibitor 3-methyladenine (3-MA) at the doses of 5, 10, and 20mM. As shown in
representative pictures, 3-MA induces a dose-dependent decrease in the number of motor neurons. 3-MA also produces changes in the morphology of surviving
motor neurons. Thus, witnessing for an autophagy-dependency of motor neuron survival. This effect is counteracted by the concomitant stimulation of the autophagy
pathway by lithium at the dose of 1 mEq/L. These data were reported in graphs plotting the 3-MA-induced reduction in motor neuron number (A, left) and the
protective effects of lithium (A, right). Values are the mean ± S.E.M. Comparisons between groups were made by using One-way ANOVA. *P ≤ 0.05 compared with
other groups in graph; **P < 0.05 compared with 3-MA 10, 20mM, and lithium (A). Scale bars = 91µm, high magnification: 19µm.
However, following lithium administration a significant increase
in the number of grains was detected in the cytoplasm. [2-
3H]Adenine was clustered specifically in very small areas
surrounding mitochondria (which is compatible with grains
diffusion constant established here: within mitochondria up
to 250 nm distance from mitochondrial contour). In keeping
with this, when lithium was administered, the distance between
[2-3H]adenine labeling silver grain clusters and mitochondria
was polarized within a range of 250 nm compared with
stochastic diffusion which was measured in vehicle-treated cells
(see Figure 1 again). Moreover, the mean size of electron
microscopy clusters surrounding mitochondria was way higher
in lithium compared with vehicle-treated cells. These data
provide for the first time an in situ mechanistic evidence for
mitochondrial biogenesis, thus lending substance to previous
results we obtained by using quantitative rtPCR or MitoTracker
Red or Green (Fornai et al., 2008a). This confirms that
autophagy inducers which work as mitophagy activators produce
a concomitant stimulation of mitochondriogenesis (Palikaras
et al., 2015a,b).
In these latter works the mitophagy flux was coupled
with the biogenesis of mitochondria. In fact, although
autophagy induction was already suggested to be tightened
with mitochondriogenesis (Fornai et al., 2008a; Ruffoli et al.,
2015), very recently, elegant data indicated how mitophagy
is coupled with biogenesis of novel mitochondria (Palikaras
et al., 2015a,b). When damaged mitochondria occur even in
physiological conditions, this triggers a dual pathway based on
SKN-1 activation, which mediates mitophagy (the removal of
damaged mitochondria), and increases mitochondrial biogenesis
(Palikaras et al., 2015a,b). Interestingly, these dual effects were
recently demonstrated for another autophagy inducer such as
resveratrol (Meira-Martins et al., 2015), which is known to
protect in ALS models (Han et al., 2012).
The significance of the present findings on motor neuron
perikarya needs to take into account what recently published by
Parone et al. (2013), who found that protecting mitochondria
within motor neuron cell body and axons in the ventral root
(through knocking out CycD thereby inducing the stabilization
of the mitochondrial transition pore), does not extend the
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FIGURE 15 | Representative localization of SOD1 in motor neurons in G93A mice. In vehicle-treated G93A mice SOD1 immunogold particles (arrows) are
localized on the mitochondrial cristae and matrix. Lithium treatment significantly reduces the immunogold labeling (arrows, A). Values are the mean ± S.E.M.
Comparisons between groups were made by using One-way ANOVA. *P ≤ 0.05 compared with other groups. Scale bars: WT vehicle, WT lithium = 0.3µm, G93A
vehicle, G93A lithium = 0.4µm, G93A vehicle (low magnification) = 1.3µm.
survival of G93A mice, despite preserving the number of motor
neurons counted within spinal cord. The occurrence of palsy
and lethality in these experimental conditions is considered to be
the consequence of the axonal degeneration which still persists
producing muscle denervation despite mitochondrial protection
(Parone et al., 2013).
If one assumes that even axonal damage is produced by
mitochondrial dysfunction, then it is likely that the threshold
for mitochondrial damage in the cell body is higher than axons.
This would explain why treatments leading to a noticeable
protection of mitochondria in the motor neuron cell body do
not guarantee for the survival of the peripheral axons. This is
in line with mice undergoing palsy and death despite a fair
sparing of motor neurons counted in the anterior horn of
the spinal cord (Parone et al., 2013). Within this scenario we
extended our analysis considering the effects of lithium within
motor neuron axons. Here we noticed a substantial difference
of mitochondrial damage in the proximal compared with distal
axons and with what observed in the cell body. In the study by
Parone et al. (2013), the occurrence of lethality and neurological
symptoms was not modified by preserving mitochondria in the
cell body and proximal axons ruling out the hegemonic role for
mitochondrial alterations in the genesis of ALS. However, in this
study axonal mitochondria were analyzed only at the level of the
spinal cord/ventral root which means at the level of proximal
axons. In the present study a clear difference was observed in
mitochondrial degeneration and protection when considering
proximal compared with distal axons. In particular, the amount
of damage at mitochondrial level and within extra-mitochondrial
structures in distal axons exceeds the damage which can be
measured in proximal axons and cell bodies and dendrites.
This indicates as mandatory to analyze the ultrastructure of
peripheral axons in order to judge about the occurrence of
axonal loss and muscle denervation, while proximal axons do not
correlate with disease severity. In keeping with this, recent studies
documented remarkable beneficial effects of lithium to enhance
motor regeneration at axonal level (Fu et al., 2014; Su et al.,
2014). This is in line with data reported here showing that lithium
produces beneficial effects in peripheral axons and muscles.
These effects are much slighter in proximal axons. The diversity
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of these axonal compartments may relate to the occurrence of
axonal jams which clogs the axonal lumen which is cleared by
lithium administration. The occurrence of axonal clogging is
likely to make the distal axonal compartment no longer reachable
by the cell body, unless a clearance of the axonal lumen is
produced. In fact, the clearance induced by lithium of axonal
lumenmatches the increase in mitochondrial density and healthy
mitochondria which was produced by lithium in distal axons. In
keeping with the diversity of effects within proximal vs. distal
axons some issues appear as contradictory. It may be difficult to
explain why the amount ofmitochondria counted in the proximal
axon of lithium-treated WT is similar to lithium- and vehicle-
administered G93A mice. In fact assuming a detrimental role
of axonal jamming to impede mitochondrial axonal transport,
one should expect that the number of mitochondria in lithium-
treated WT was similar to vehicle-administered WT. Again
G93A mice administered lithium should posses a number of
mitochondria similar to that counted in G93Amice administered
vehicle. However this point, despite being unexpected at first
glance, confirms the profound difference between proximal
and distal axon as distinct compartments in motor neuron
pathology. In fact, when looking at distal axons, we measured the
highest amount of mitochondrial damage and the presence of a
significant protection by lithium. This is in line with the fact that
proximal axons in the spinal cord do not represent the culprit
of ALS degeneration which is instead localized within distant
peripheral axons within muscles.
This is substantiated by the placement of axonal jamming
which was detected upstream to distal axons and it was removed
by lithium administration. Still, one might wonder why a lack of
mitochondria in the proximal axon still occurs in lithium-treated
mice. This is likely not to be a critical point for axonal physiology
since, as in the cell bodies, proximal axons are not the site
of neurotransmitter release and maximal energy consumption.
These findings strengthen the introductory hypothesis of the
manuscript that proximal compared with distal axonal damage
is key to understand ALS pathology. Similarly functional data
indicating impairment of axonal transport of mitochondria
(Magrané et al., 2012, 2014) are now grounded on a solid
morphological evidence provided here by axonal jamming. These
data do not contradict the data obtained by Parone et al. (2013).
In fact in their study these Authors documented the
preservation of mitochondria in the cell body and axons at the
level of the ventral root (which means proximal axons), while
the peripheral axonal degeneration and muscle denervation was
still ongoing. In this study there was no ultrastructural analysis of
mitochondria within peripheral axons where degeneration and
denervation were taking place. The present findings shift the
focus toward the very distal axonal compartment compared with
proximal axons as key to understand the key role of mitochondria
in producing axonal degeneration, muscle denervation and the
course of ALS. It is likely that other neuronal alterations beyond
mitochondria play a fundamental role in ALS; nonetheless
the experiments reported here demonstrate that mitochondrial
protection within distal axons is beneficial. Of course additional
targets need to be considered. In fact, axonal clogging which
occurs within axonal lumen is likely to play a critical role. Again,
a frank beneficial effect on muscle ultrastructure shown here
may improve the disease course also independently from motor
innervation which remains fundamental. The protective effects
of lithium described here on distal axonal mitochondria, axonal
clogging and muscle derangement may not be powerful enough
to arrest the disease course although they offer a solid proof of
principle on how to target the critical points in the motor system
which determine the onset and progression of motor symptoms
as well as survival in ALS.
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